Conditions Not Requiring Specific Therapy
Not every deviation from population norms is a pathology requiring medication. There is a range of conditions where intervention in the endocrine system is unjustified:
- Physiological variants. These include familial short stature, constitutional growth delay, and familial tall stature. Treatment in such cases is not indicated. The child's final height will directly correlate with the genetic (familial) prognosis.
- Psychosocial growth retardation. This condition is also known as deprivation dwarfism. Its pathogenesis is inextricably linked to the impact of chronic stress on the child's body. Specific medical treatment is not required: normalization of physical development rates (so-called catch-up growth) occurs spontaneously. To achieve this, it is sufficient to eliminate negative factors and place the patient in a favorable social and psychological environment.
- Syndromic tall stature. Specific therapy aimed at artificial correction (arrest) of growth is not performed. However, such patients require careful multidisciplinary monitoring. Management is carried out by a geneticist in conjunction with narrow specialists for timely control and management of concomitant severe clinical manifestations of a specific genetic syndrome.
Etiopathogenetic Therapy of Growth Retardation
If physical developmental delay is caused by a specific disease, the strategy comes down to eliminating the root cause or replacing the deficient growth factor. The approach is strictly differentiated.
Somatogenic Growth Retardation
The basis of treatment is maximum compensation or complete elimination of the primary somatic disease that caused the deficit in body weight and length. As soon as the main pathological process is brought under control, physical development normalizes.
- Examples: successful surgical correction of congenital heart defects or a strict lifelong gluten-free diet in celiac disease predictably lead to a rapid restoration of normal growth rates.
Endocrine disorders
- Hypothyroidism. In case of thyroid hormone deficiency, lifelong hormone replacement therapy (HRT) is indicated. Levothyroxine sodium preparations are used. Once euthyroidism is achieved, the child's growth rates completely normalize.
- Growth hormone deficiency (pituitary dwarfism, hypopituitarism). The main treatment method is HRT using modern recombinant somatropic hormone (GH) preparations.
- Dosing regimen: calculation of the required daily dose is performed strictly based on the patient's body weight.
- Route of administration: the drug is administered via subcutaneous injections. The procedure is performed daily, strictly in the evening. This is necessary to maximally mimic the physiological circadian rhythm of endogenous growth hormone secretion.
Special clinical situations
Certain genetic and bone pathologies require a special approach to prescribing growth-stimulating therapy, as standard regimens may be ineffective.
- Syndromic growth retardation. In some chromosomal abnormalities, somatotropin therapy can produce a positive effect. A classic example is Turner syndrome. However, to overcome tissue resistance and achieve a clinically significant result, high doses of GH preparations are required.
- Chondrodysplasias. In cases of systemic skeletal lesions (e.g., in achondroplasia), specific growth-stimulating hormone therapy is completely ineffective. This is due to the pronounced congenital resistance of the cartilage tissue itself to the effects of growth factors. Such patients are managed exclusively by a medical board consisting of an endocrinologist, a geneticist, and an orthopedic surgeon.
To memorize the response to GH therapy: HTS. Hypopituitarism — standard dose, Turner — high dose, Chondrodysplasia — does not work (cartilage resistance).
Class and exam questions
At what time of day is it necessary to administer recombinant growth hormone?
Injections are performed daily in the evening. This makes it possible to simulate the normal physiological rhythm of somatotropin secretion, the peak of which normally occurs during nighttime hours.
Is drug treatment required for psychosocial growth retardation?
No, medications are not prescribed. It is necessary to eliminate chronic stress factors; after placement in a favorable environment, the process of catch-up growth spontaneously begins in the child.
Why is somatotropin not prescribed for chondrodysplasias?
In chondrodysplasias, hormone therapy is ineffective due to severe cartilage tissue resistance. Growth plates do not respond to stimulation due to a structural defect of the cartilage itself.
How is somatogenic growth retardation corrected?
The basis of therapy is the treatment of the primary disease. For example, adherence to a gluten-free diet in celiac disease or surgical correction of a heart defect automatically restores growth rates.
What else to study on this topic
- Pathogenesis of Deprivation Dwarfism
- Differential Diagnosis of Constitutional Growth Delay and Pituitary Dwarfism
- Multidisciplinary Approach in Turner Syndrome
- Clinical Presentation and Orthopedic Correction of Chondrodysplasias
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Full Study Guide on "Treatment of Growth Disorders" and 3,738 Other Pages of the Subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in the section «Chapter 11. Endocrine Diseases in Children»
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.